Novel antibodies against receptors, protein kinase inhibitors, and siRNA, targeting both signal transduction and gene expression, will certainly lead to the therapeutic approaches that will be developed and used in this new century. Preface.
Diederich
Marc
M
Laboratoire de Biologie Moléculaire et Cellulaire du Cancer Hôpital Kirchberg, L-2540 Luxembourg.
D000906:Antibodies / Q000276:immunology / Q000494:pharmacology* / Q000627:therapeutic use; D004358:Drug Therapy / Q000379:methods / Q000639:trends; D015870:Gene Expression / Q000187:drug effects*; D006801:Humans; D047428:Protein Kinase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000235:genetics; D011956:Receptors, Cell Surface / Q000276:immunology; D015398:Signal Transduction / Q000187:drug effects* / Q000235:genetics / Q000502:physiology
D000906:Antibodies; D047428:Protein Kinase Inhibitors; D034741:RNA, Small Interfering; D011956:Receptors, Cell Surface